Patents Assigned to Cardiac Pacemaker, Inc.
-
Patent number: 11382552Abstract: An apparatus comprises an arrhythmia detection circuit configured to: receive a cardiac signal representative of cardiac activity of a subject; apply a first arrhythmia detection criteria to the received cardiac signal; apply, in response to the applied first arrhythmia detection criteria producing a positive indication of arrhythmia, a second arrhythmia detection criteria to the received cardiac signal, wherein the second arrhythmia detection criteria is more specific to detection of arrhythmia than the first detection criteria; detect, in response to the applied first and second arrhythmia detection criteria, a sensing event indicating one or both of the first and second arrhythmia detection criteria are susceptible to false indications of arrhythmia; and adjust, in response to a detected sensing event, sensitivity or specificity of one or both of the first and second arrhythmia detection criteria.Type: GrantFiled: July 23, 2018Date of Patent: July 12, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: David L. Perschbacher, Sunipa Saha, Deepa Mahajan
-
Patent number: 11376420Abstract: A terminal tool includes a main body, an electrical connector body, and an electrical connector. The main body includes a distal clamping section and a shaft. The shaft includes a window and a first lumen extending through the shaft for receiving a terminal end of an implantable lead. The electrical connector body includes a second lumen and is independently rotatable with respect to the main body. The shaft at least partially extends through the second lumen. The electrical connector is coupled to the electrical connector body and extends at least partially through the window of the shaft.Type: GrantFiled: January 16, 2020Date of Patent: July 5, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Andrew L. De Kock, G. Shantanu Reddy, Matthew J. Miller, Kenneth Matrin Stein, Lili Liu
-
Patent number: 11369794Abstract: Various aspects of the present subject matter relate to an implantable device. Various device embodiments comprise at least one port to connect to at least one lead with at least electrode, stimulation circuitry connected to the at least one port and adapted to provide at least one neural stimulation therapy to at least one neural stimulation target using the at least one electrode, sensing circuitry connected to the at least one port and adapted to provide a sensed signal, and a controller connected to the stimulation circuitry to provide the at least one neural stimulation therapy and to the sensing circuitry to receive the sensed signal. In response to a triggering event, the controller is adapted to switch between at least two modes. Other aspects and embodiments are provided herein.Type: GrantFiled: October 9, 2019Date of Patent: June 28, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Imad Libbus, Andrew P. Kramer, William J. Linder, Jeffrey E. Stahmann
-
Patent number: 11369799Abstract: An apparatus includes a housing including a bore and a housing groove within the bore and located on an inner surface of the housing; and a coil spring located within the housing and mounted within the housing groove, wherein the housing groove has a non-uniform radius such that the coil spring defines zones of relative low contact force and zones of relative high contact force.Type: GrantFiled: January 21, 2020Date of Patent: June 28, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: William J. Linder, James Blilie, Scott Dahl, Arthur J. Foster, Keith R. Maile
-
Patent number: 11363993Abstract: Systems and methods are described for subject rehospitalization management. In an example, multiple physiologic signals can be obtained from a subject using multiple sensors. In response to a hospitalization event, pre-hospitalization characteristics of the multiple physiologic signals can be identified. Post-hospitalization characteristics of the multiple physiologic signals can be identified, including characteristics that differ from their corresponding pre-hospitalization characteristics. Later subsequent physiologic signals can be further monitored after the hospitalization event, such as using the same multiple sensors, and subsequent physiologic signal characteristics can be identified. In an example, a heart failure diagnostic indication can be determined using information about the pre-hospitalization characteristics, the post-hospitalization characteristics, and the subsequent characteristics.Type: GrantFiled: December 18, 2018Date of Patent: June 21, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Qi An, Barun Maskara, Julie A. Thompson
-
Patent number: 11357440Abstract: An apparatus comprises a magnetic field detection circuit, a cardiac signal sensing circuit, a memory circuit, a control circuit, and an arrhythmia detection circuit. The cardiac signal sensing circuit generates a cardiac signal representative of cardiac activity of a subject when coupled to sensing electrodes. The control circuit is operatively coupled to the magnetic field detection circuit; the cardiac signal sensing circuit, and the memory circuit. The control circuit stores cardiac signal data determined using the sensed cardiac signal, receives an indication of magnetic field detection by the magnetic field detection circuit, stores data obtained using the sensed cardiac signal during the magnetic field detection, and stores an identifier indicating the magnetic field detection in association with the data. The arrhythmia detection circuit processes the cardiac signal data to detect a cardiac arrhythmia event and confirm the cardiac arrhythmia event according to the magnetic field indication.Type: GrantFiled: January 29, 2019Date of Patent: June 14, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Binh C. Tran, Mitchell D. Lanz, Scott R. Vanderlinde
-
Patent number: 11357441Abstract: Systems and methods for managing cardiac arrhythmias are discussed. A data management system receives a first detection algorithm including a detection criterion for detecting a cardiac arrhythmia. An arrhythmia detector detects arrhythmia episodes from a physiologic signal using a second detection algorithm that is different from and has a higher sensitivity for detecting the cardiac arrhythmia than the first detection algorithm. The arrhythmia detector assigns a detection indicator to each of the detected arrhythmia episodes. The detection indicator indicates a likelihood that the detected arrhythmia episode satisfies the detection criterion of the first detection algorithm. The system prioritizes the detected arrhythmia episodes according to the assigned detection indicators, and outputs the arrhythmia episodes to a user or a process according to the episode prioritization.Type: GrantFiled: January 29, 2019Date of Patent: June 14, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: David L. Perschbacher, Sunipa Saha, Deepa Mahajan
-
Publication number: 20220176110Abstract: Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may include a proximal section including a deflection mechanism for deflecting the proximal section, and a distal holding section extending distally of a distal end of the proximal section and defining a cavity therein for receiving an implantable leadless pacing device. The distal holding section may be structured to have portions that flex and bend while allowing the implantable device to be recaptured within the distal holding section.Type: ApplicationFiled: February 23, 2022Publication date: June 9, 2022Applicant: CARDIAC PACEMAKERS, INC.Inventors: BENJAMIN J. HAASL, BRIAN L. SCHMIDT
-
Patent number: 11350848Abstract: Systems and methods provide for assessing the heart failure status of a patient and, more particularly, to generating a trend parameter based on a distribution of the patient's respiration rate. Systems and methods provide for detecting, using an implantable device or a patient-external device, patient respiration and computing a respiration rate based on the detected patient respiration. A distribution of the respiration rate is calculated, and a trend parameter based on the respiration rate distribution is generated. The trend parameter is indicative of a patient's heart failure status. An output signal indicative of the patient's heart failure status may be generated based on the trend parameter.Type: GrantFiled: February 11, 2013Date of Patent: June 7, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Viktoria Averina, Yi Zhang, Yousufali Dalal
-
Patent number: 11357125Abstract: A medical device includes a hybrid circuitry assembly and a core circuitry support structure. The core circuitry support structure includes a frame defining a cavity configured to receive at least a portion of the hybrid circuitry assembly. An outer surface of the frame is shaped to correspond to an inside surface of a core assembly housing configured to enclose the hybrid circuitry assembly and the core circuitry support structure.Type: GrantFiled: December 23, 2020Date of Patent: June 7, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Jean M. Bobgan, David P. Stieper, Joseph Prescott
-
Patent number: 11351386Abstract: Methods and tool kits for implanting a lead subcutaneously. Examples include tool kits and methods for establishing first and second subcutaneous tunnels at an angle relative to one another to facilitate introduction of a lead to the subcutaneous space. In an example, a tunneling tool and lead assembly are advanced simultaneously into the subcutaneous space. The tunneling tool may include a curved region configured to transition the tool from the first subcutaneous tunnel to the second subcutaneous tunnel with the use of a single incision.Type: GrantFiled: August 17, 2018Date of Patent: June 7, 2022Assignee: CARDIAC PACEMAKERS, INC.Inventors: G. Shantanu Reddy, Andrew L. De Kock
-
Patent number: 11338145Abstract: Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for pacing a HIS bundle of a patient. The apparatuses, systems, and methods may include applying stimulation energy through one or more of a plurality of electrodes to direct a stimulation locus and pace a HIS bundle of a patient.Type: GrantFiled: January 17, 2019Date of Patent: May 24, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh H. Thakur, Allan C. Shuros, Brian Soltis, Juan G. Hincapie, Qi An, Yinghong Yu, Keith R. Maile
-
Patent number: 11338135Abstract: Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a medical device system for treating a cancerous tumor is described. The medical device system can include one or more electric field generating electrodes and an electric field shaping element configured to be implanted along with the one or more electric field generating electrodes. The electric field shaping element can be made from a material that alters the spatial area of tissue exposed to the electric field. Other embodiments are also included herein.Type: GrantFiled: October 22, 2018Date of Patent: May 24, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Patent number: 11340236Abstract: Provided herein are methods that include (i) determining a level of soluble ST2 in a biological sample from a subject, (i) comparing the level of soluble ST2 in the biological sample to a reference level of soluble ST2 (e.g., a level of soluble ST2 in the subject at an earlier time point), and (iii) selecting, implanting, replacing, or reprogramming an implanted cardiac device, e.g., an ICD, CRT, or CRT-D device, for a subject having an elevated level of soluble ST2 in the biological sample compared to the reference level of soluble ST2, or selecting a subject for participation in, or stratifying a subject participating in, a clinical study of a treatment for reducing the risk of a ventricular tachyarrhythmia (VTA) event. Also provided are methods for evaluating the risk of a VTA event in a subject. Also provided are kits for performing any of these methods.Type: GrantFiled: September 6, 2019Date of Patent: May 24, 2022Assignees: Critical Care Diagnostics, Inc., Cardiac Pacemakers, Inc.Inventors: James V. Snider, Timothy Edward Meyer, Craig Michael Stolen, Robert W. Gerwien
-
Patent number: 11324860Abstract: An implantable medical device includes a polymer substrate and at least one nanofiber. The polymer substrate includes a surface portion extending into the polymer substrate from a surface of the substrate. The at least one nanofiber includes a first portion and a second portion. The first portion is interpenetrated with the surface portion of the substrate, and mechanically fixed to the substrate. The second portion projects from the surface of the substrate.Type: GrantFiled: August 9, 2017Date of Patent: May 10, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: David R. Wulfman, Danielle Frankson, Adeniyi O. Aremu, Angelo Fruci, Gregory J. Sherwood, Mary M. Byron, Joseph T. Delaney, Jr., Adam McGraw
-
Patent number: 11318303Abstract: A device for the active fixation of an implantable medical lead includes a housing, a tine assembly, an electrode, and a rotatable shaft. The housing includes a proximal end for connecting to the lead and a distal end opposite the proximal end. The housing defines a housing lumen extending between the proximal end and a recess adjacent to the distal end. The tine assembly is disposed within the housing lumen and includes at least one tine configured to self-bias from a linear configuration within the housing to a curved configuration outside of the housing. The electrode assembly is disposed at the distal end of the housing and includes a plurality of electrodes. The rotatable shaft extends through the housing lumen and is configured to engage the tine assembly such that rotation of the shaft transitions the at least one tine between the linear configuration and the curved configuration.Type: GrantFiled: April 19, 2019Date of Patent: May 3, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Allan C. Shuros, Arthur J. Foster, Keith L. Herrmann, Deepa Mahajan, Stephen J. Hahn
-
Patent number: 11318313Abstract: This document discusses, among other things, systems and methods to determine a response between received cardiac electrical information from a subject, such as a time of a P wave, and received cardiac acceleration information of the subject, such as a time of a first heart sound (S1) or a second heart sound (S2), across a set of stimulation signals provided to the subject at different AVD intervals, and determining one or more cardiac resynchronization therapy (CRT) parameters using an inflection point of the determined response.Type: GrantFiled: April 10, 2020Date of Patent: May 3, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Yinghong Yu, Krzysztof Z. Siejko, Qi An
-
Patent number: 11311244Abstract: This document discusses, among other things, systems and methods to produce a composite heart sound signal of a patient using a first signal including heart sound information over a first physiologic interval and a second signal including heart sound information over the first physiologic interval.Type: GrantFiled: August 27, 2018Date of Patent: April 26, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Jonathan Bennett Shute, Bin Mi, Pramodsingh Hirasingh Thakur, Qi An
-
Patent number: 11311731Abstract: This document discusses, among other things, systems and methods to determine a response curve between received cardiac electrical information from a subject, such as a time of a P wave, and received cardiac acceleration information of the subject, such as a time of a first heart sound (S1) or a second heart sound (S2), to a set of stimulation signals provided to the subject at different AVD intervals. In certain examples, one or more cardiac resynchronization therapy (CRT) parameters can be determined for the subject using the determined response curve.Type: GrantFiled: April 10, 2020Date of Patent: April 26, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Yinghong Yu, Krzysztof Z. Siejko, Qi An
-
Patent number: 11305125Abstract: An implantable medical device (IMD) that includes a housing, a first electrode secured relative to the housing, a second electrode secured relative to the housing, and a gyroscope secured relative to the housing. The IMD may include circuitry in the housing in communication with the first electrode, the second electrode, and the gyroscope. The circuitry may be configured to determine and store a plurality of torsion data measurements, from which a representation of a twist profile may be determined.Type: GrantFiled: August 8, 2019Date of Patent: April 19, 2022Assignee: CARDIAC PACEMAKERS, INC.Inventors: Bin Mi, Pramodsingh Hirasingh Thakur, Jeffrey E. Stahmann, Keith R. Maile, Qi An, Brendan Early Koop, Yinghong Yu, Viktoria A. Averina, Michael J. Kane, Krzysztof Z. Siejko